Michael B Fallon
Overview
Explore the profile of Michael B Fallon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Danpanichkul P, Duangsonk K, Chen V, Saokhieo P, Dejvajara D, Sukphutanan B, et al.
Hepatology
. 2025 Feb;
PMID: 39937958
Backgrounds Aims: Hepatitis B virus (HBV)-related liver disease ranks as the seventh leading cause of mortality. Despite advances in prevention and treatment, global disparities in the burden of primary liver...
2.
Danpanichkul P, Duangsonk K, Kalligeros M, Fallon M, Vuthithammee C, Pan C, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):959-970.
PMID: 39757456
Objective: Primary liver cancer (PLC) is projected to be the third leading cause of cancer mortality in the United States in 2040. We examine the burden of PLC in the...
3.
Krowka M, DuBrock H, Raevens S, Fallon M
Hepatology
. 2024 Dec;
PMID: 39723999
Portopulmonary hypertension (POPH), a form of pulmonary artery hypertension, occurs because of portal hypertension. Pulmonary hemodynamics and right heart function are key entities that are considered when diagnosing and treating...
4.
Faulkner C, Aboona M, Surendra L, Rangan P, Ng C, Huang D, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39675403
Background & Aims: Significant health disparities exist in metabolic dysfunction-associated steatotic liver disease (MASLD), driven by social determinants of health (SDOH). Few studies have explored neighborhood-level SDOH in MASLD. Methods:...
5.
Danpanichkul P, Duangsonk K, Diaz L, Chen V, Rangan P, Sukphutanan B, et al.
Drug Alcohol Depend
. 2024 Nov;
266:112495.
PMID: 39603063
Background: Substance use disorders (SUDs) play a major role in global preventable disability and mortality. Even though they impact patients of all ages, adolescents and young adults (AYAs) are at...
6.
Cecil C, Moutchia J, Krowka M, DuBrock H, Forde K, Krok K, et al.
Liver Transpl
. 2024 Nov;
PMID: 39560494
Patients with chronic liver disease commonly have abnormal lung function; however, the impact of smoking on outcomes in these patients is unknown. We hypothesized current or past smoking would be...
7.
Danpanichkul P, Suparan K, Tothanarungroj P, Dejvajara D, Rakwong K, Pang Y, et al.
Gut
. 2024 Sep;
74(1):26-34.
PMID: 39242191
Background: Gastrointestinal cancers comprise nearly one-third of global mortality from cancer, yet the comprehensive global burden of these cancers remains uninvestigated. Objective: We aimed to assess the global, regional and...
8.
Aboona M, Danpanichkul P, Chen V, Rangan P, Kim D, Alkhouri N, et al.
J Gastroenterol Hepatol
. 2024 Aug;
39(11):2456-2463.
PMID: 39175201
Background And Aim: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a leading cause of chronic liver disease worldwide. A new entity termed MetALD has also been described and is...
9.
Liu B, Yi D, Xia X, Ramirez K, Zhao H, Cao Y, et al.
Circulation
. 2024 Jul;
150(5):414-417.
PMID: 39074180
No abstract available.
10.
Liu B, Yi D, Ma X, Ramirez K, Zhao H, Xia X, et al.
J Respir Biol Transl Med
. 2024 Jul;
1(2).
PMID: 38974505
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by high blood pressure in the pulmonary arteries, which can potentially lead to heart failure over time. Previously, our lab found...